Omidreza Sedigh

Omidreza Sedigh

Auto-generated profile, based on publicly available information

Omidreza Sedigh

Division of Urology, Department of Surgical Sciences, Città Della Salute e Della Scienza Hospital and University of Turin, Turin, Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Tumori Journal
Verified
Journal Article
Open access
OSOmidreza Sedigh
Omidreza Sedigh
MPMirko Preto
Mirko Preto
FSFarzin Soleimanzadeh
Farzin Soleimanzadeh
GMGiancarlo Marra
Giancarlo Marra
MFMarco Falcone
Marco Falcone
PGPaolo Gontero
Paolo Gontero
Purpose: Inguinal lymphadenectomy (iLAD) reduces mortality in patients with cN0 penile cancer but yields high complication rates. Thus, its prophylactic role has been questioned and dynamic sentinel node biopsy (DSNB) was introduced to select men who should undergo the procedure. Our aim was to investigate the accuracy of a contemporary DSNB cohort. Methods: We performed a retrospective analysis of ≥T1 or ≥G2 cN0 penile cancer undergoing perioperative DSNB from June 2009 to June 2015 at a tertiary referral center. We excluded men with <18 months follow-up or with local recurrence after primary curative treatment. Complications were graded according to the Clavien-Dindo classification. Results: Thirty-five men underwent DSNB; 85.71% had ≤T2 penile cancer with ≤G2a histology. Per groin detection rate was 80% (scintigraphy being positive bilaterally in 60% and unilaterally in 20.0%). In no cases did DSNB prolong the postoperative course compared to primary surgery. Nine men (n = 15/109 nodes removed) had positive results, 8 of whom underwent iLAD. Among negative DSNB patients, 2 developed nodal penile cancer recurrence; none of them had node biopsy due to inconclusive scintigraphy. At a median follow-up of 42 months (interquartile range 30-78 months), if considering only men with scintigraphy detected inguinal nodes, per-patient sensitivity and specificity were 50% and 80% whereas positive predictive value and negative predictive value were 25% and 92.3%, respectively. Conclusions: Perioperative DSNB is a safe procedure, yielding promising results when performed at a tertiary referral center. Future prospective large studies are needed to investigate how to optimize detection rate and reduce false-negative rates.

17 November 2021 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
EGEster Gallo
Ester Gallo
SMSilvia Mingozzi
Silvia Mingozzi
AMAlberto Mella
Alberto Mella
FFFabrizio Fop
Fabrizio Fop
RPRoberto Presta
Roberto Presta
LBLuigi Biancone
Luigi Biancone
Rare diseases (RDs) encompass many difficult-to-treat conditions with different characteristics often associated with end-stage renal disease (ESRD). However, data about transplant outcomes in adult patients are still lacking and limited to case reports/case series without differentiation between immunological/non-immunological RDs. Retrospective analysis among all adult kidney transplanted patients (KTs) with RDs (RDsKT group) performed in our high-volume transplantation center between 2005 and 2016. RDs were classified according to the Orphanet code system differentiating between immunological and non-immunological diseases, also comparing clinical outcomes and temporal trends to a control population without RDs (nRDsKT). Among 1381 KTs, 350 patients (25.3%) were affected by RDs (RDsKTs). During a f/up > 5 years [median 7.9 years (4.8–11.1)], kidney function and graft/patient survival did not differ from nRDsKTs. Considering all post-transplant complications, RDsKTs (including, by definition, patients with primary glomerulopathy except on IgA nephropathy) have more recurrent and de-novo glomerulonephritis (14.6% vs. 9.6% in nRDsKTs; p = 0.05), similar rates of de-novo cancers, post-transplant diabetes, dysmetabolism, hematologic disorders, urologic/vascular problems, and lower infectious episodes than nRDsKTs (63.7% vs 72.7%; p = 0.013). Additional stratification for immunological and non-immunological RDsKTs or transplantation periods (before/after 2010) showed no differences or temporal trends between groups. Kidney transplant centers are deeply involved in RDs management. Despite their high-complex profile, both immunological and non-immunological RDsKTs experienced favorable patients’ and graft survival.

9 October 2019 in European Urology Supplements
Verified
Journal Article
Closed access
LTL. Timpano
L. Timpano
MFMarco Falcone
Marco Falcone
MPMirko Preto
Mirko Preto
CCC. Ceruti
C. Ceruti
OSO. Sedigh
O. Sedigh
PGPaolo Gontero
Paolo Gontero

1 June 2021 in European Urology
Verified
Journal Article
Closed access
KRK. Van Renterghem
K. Van Renterghem
BJB. Jacobs
B. Jacobs
FYF. Yafi
F. Yafi
DOD. Osmonov
D. Osmonov
DRD. Ralph
D. Ralph
IMI. Mikoniatis
I. Mikoniatis